BIOUX
Price
$67.55
Change
-$1.29 (-1.87%)
Updated
Jun 17 closing price
Net Assets
2.17B
VIGIX
Price
$264.40
Change
-$3.69 (-1.38%)
Updated
Jun 17 closing price
Net Assets
393.82B
Interact to see
Advertisement

BIOUX vs VIGIX

BIOUX vs VIGIX Comparison Chart in %
View a ticker or compare two or three
VS
BIOUX vs. VIGIX commentary
Jun 18, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIOUX is a Hold and VIGIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGIX has more cash in the bank: 394B vs. BIOUX (2.17B). VIGIX pays higher dividends than BIOUX: VIGIX (0.37) vs BIOUX (0.00). BIOUX was incepted earlier than VIGIX: BIOUX (10 years) vs VIGIX (28 years). BIOUX (1.04) is less costly to investors than VIGIX (0.03). BIOUX is a more actively managed with annual turnover of: 30.00 vs. VIGIX (12.00). BIOUX (5000000) and VIGIX (5000000) have matching initial minimum investment requirements. BIOUX annual gain was more profitable for investors over the last year : 29.04 vs. VIGIX (23.91). VIGIX return over 5 years is better than : 88.04 vs. BIOUX (47.07).
BIOUXVIGIXBIOUX / VIGIX
Total Expense Ratio1.040.033,467%
Annual Report Gross Expense Ratio1.040.033,467%
Fund Existence10 years28 years-
Gain YTD16.0656.745238%
Front LoadN/AN/A-
Min. Initial Investment50000005000000100%
Min. Initial Investment IRAN/AN/A-
Net Assets2.17B394B1%
Annual Yield % from dividends0.000.37-
Returns for 1 year29.0423.91121%
Returns for 3 years96.8286.14112%
Returns for 5 years47.0788.0453%
Returns for 10 yearsN/A392.24-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NAIGX40.11N/A
N/A
Nuveen International Value A
SAREX12.64N/A
N/A
SA Real Estate Securities
EMGDX43.48N/A
N/A
Allspring Emerging Markets Equity R6
RNWHX107.35N/A
N/A
American Funds New World R5E
GSBDX20.49N/A
N/A
Goldman Sachs Small Cap Growth A